United Therapeutics UTHR Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's deferred tax assets?
- United Therapeutics (UTHR) reported deferred tax assets of $335.4M in Q1 2026.
- How has United Therapeutics's deferred tax assets changed year-over-year?
- United Therapeutics's deferred tax assets decreased by 26.5% year-over-year, from $456.6M to $335.4M.
- What is the long-term trend for United Therapeutics's deferred tax assets?
- Over 5 years (2020 to 2025), United Therapeutics's deferred tax assets has grown at a 8.4% compound annual growth rate (CAGR), from $238.6M to $357.7M.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.